文献类型： 外文期刊

作者： Yuan, Jiahao ¹ ; Wu, Daren ¹ ; Liu, Jiang ¹ ; Yang, Hangran ¹ ; Su, Yingjian ¹ ; Zhang, Lingyu ¹ ; Lin, Shan ¹ ; Zhao, Zhixia ³ ; Kang, Feng ³ ; Li, Jian ¹ ;

作者机构： 1.Jimei Univ, Coll Food & Biol Engn, 43 Yindou Rd, Xiamen, Fujian, Peoples R China

2.Fujian Prov Engn Technol Res Ctr Marine Funct Foo, Xiamen 361021, Peoples R China

3.Xinjiang Acad Agr Sci, Inst Agrofood Storage & Proc, Urumqi 830091, Xinjiang, Peoples R China

关键词： Citri Reticulatae Pericarpium; Bioactive compounds; XOD; Molecular docking; Uric acid-lowering activity

期刊名称：PLANT FOODS FOR HUMAN NUTRITION （ 影响因子：3.6； 五年影响因子：4.1 ）

ISSN： 0921-9668

年卷期： 2025 年 80 卷 2 期

页码：

收录情况： SCI

摘要： Citri Reticulatae Pericarpium, the dried and mature peel of wild Citrus reticulata Blanco and its cultivated varieties in the rutaceae family, is an important herb and condiment in Chinese medicine. At present, there are few relevant reports, especially in-depth reports, on the discovery of effective anti-gout natural products from CRP. In this study, four compounds were extracted and characterized from CRP using 70% ethanol, RP-C18, thin layer chromatography (TLC), Sephadex LH-20, high performance liquid chromatography (HPLC), and nuclear magnetic resonance spectroscopy (NMR). Additionally, monomer compounds (apigenin, luteolin) in CRP, along with those isolated from CRP, were investigated through molecular docking and in vitro assessment of their XOD inhibitory activity. Notably, the lowest binding energy (-10.3 kcal/mol) and IC50 value (76.24 mu g/mL) denoted a strong inhibitory effect of isosakuranetin with XOD. Further studies showed that isosakuranetin could significantly reduce XOD activity and uric acid levels in xanthine-induced BRL-3A cells. This research elucidates, for the first time, the uric acid-lowering effects of isosakuranetin, offering valuable insights into the potential mechanisms underlying its properties. This study provides a basis for the development of uric acid-lowering products from CRP and in-depth mechanism research of uric acid-lowering compounds.